Lupus Research Alliance Awards $6M to Two Teams for Personalized Treatment Research

Event summary

  • Lupus Research Alliance awarded $3M each to two research teams for 2025 Global Team Science Awards.
  • Teams led by Drs. Deepak Rao & Alexandra-Chloe Villani and Dr. Caroline Jefferies will study lupus heterogeneity and treatment response.
  • Research focuses on biomarkers for personalized treatment and mitochondrial stress in lupus progression.
  • GTSA program, established in 2020, has previously funded research on gut microbes' role in lupus.

The big picture

The Lupus Research Alliance's $6M investment in personalized treatment research reflects the growing emphasis on precision medicine in autoimmune disease management. With lupus affecting millions worldwide and current treatments lacking predictability, these grants aim to bridge critical gaps in understanding disease heterogeneity. The program's track record of funding impactful research, such as the gut microbiome study, underscores its role in driving innovation in lupus therapeutics.

What we're watching

Research Outcomes
Whether the teams can identify actionable biomarkers for lupus treatment personalization.
Funding Impact
How the $6M in grants will accelerate lupus research compared to previous GTSA-funded studies.
Industry Collaboration
The pace at which these findings could lead to partnerships with pharmaceutical companies.